Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin

Por Trigo, José M., Zimmer, Andreas, Maldonado, Rafael
Publicado em 2009

Screening and Evaluation of Medications for Treating Cannabis Use Disorder

Por Panlilio, Leigh V., Justinova, Zuzana, Trigo, Jose M., Le Foll, Bernard
Publicado no Int Rev Neurobiol (2016)

Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling

Por Gueye, Aliou B., Trigo, Jose M., Vemuri, Kiran V., Makriyannis, Alexandros, Le Foll, Bernard
Publicado no Behav Pharmacol (2016)

Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach

Por Foll, Bernard Le, Pushparaj, Abhiram, Pryslawsky, Yaroslaw, Forget, Benoit, Vemuri, Kiran, Makriyannis, Alexandros, Trigo, Jose M.
Publicado em 2013

Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights

Por Gamaleddin, Islam Hany, Trigo, Jose M., Gueye, Aliou B., Zvonok, Alexander, Makriyannis, Alexandros, Goldberg, Steven R., Le Foll, Bernard
Publicado no Front Psychiatry (2015)

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings

Por Trigo, Jose M., Lagzdins, Dina, Rehm, Jürgen, Selby, Peter, Gamaleddin, Islam, Fischer, Benedikt, Barnes, Allan J., Huestis, Marilyn A., Le Foll, Bernard
Publicado no Drug Alcohol Depend (2016)

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB(2) Receptors

Por Aracil-Fernández, Auxiliadora, Trigo, José M, García-Gutiérrez, María S, Ortega-Álvaro, Antonio, Ternianov, Alexander, Navarro, Daniela, Robledo, Patricia, Berbel, Pere, Maldonado, Rafael, Manzanares, Jorge
Publicado em 2012

5-HT(2C) Receptor Desensitization Moderates Anxiety in 5-HTT Deficient Mice: From Behavioral to Cellular Evidence

Por Martin, Cédric BP, Martin, Vincent S., Trigo, José M., Chevarin, Caroline, Maldonado, Rafael, Fink, Latham H., Cunningham, Kathryn A., Hamon, Michel, Lanfumey, Laurence, Mongeau, Raymond
Publicado no Int J Neuropsychopharmacol (2015)

Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related he...

Por Pajares, Bella, Trigo, Jose M, Toledo, Maria D, Álvarez, Martina, González-Hermoso, Carlos, Rueda, Antonio, Medina, Jose A, Luque, Vanessa de, Jerez, Jose M, Alba, Emilio
Publicado em 2013

The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability

Por Gueye, Aliou B., Pryslawsky, Yaroslaw, Trigo, Jose M., Poulia, Nafsika, Delis, Foteini, Antoniou, Katerina, Loureiro, Michael, Laviolette, Steve R., Vemuri, Kiran, Makriyannis, Alexandros, Le Foll, Bernard
Publicado no Int J Neuropsychopharmacol (2016)

Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment For Cannabis Dependence: A case series

Por Trigo, Jose M., Soliman, Alexandra, Staios, Gregory, Quilty, Lena, Fischer, Benedikt, George, Tony P., Rehm, Jurgen, Selby, Peter, Barnes, Allan J., Huestis, Marilyn A., Le Foll, Bernard
Publicado no J Addict Med (2016)

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Por Nielsen, Suzanne, Sabioni, Pamela, Trigo, Jose M, Ware, Mark A, Betz-Stablein, Brigid D, Murnion, Bridin, Lintzeris, Nicholas, Khor, Kok Eng, Farrell, Michael, Smith, Andrew, Le Foll, Bernard
Publicado no Neuropsychopharmacology (2017)